Safety Study of MGAH22 in HER2-positive Carcinomas

Clinical trial NCT01148849 · COMPLETED

Trial details

NCT number: NCT01148849
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Gastric Cancer

Start date: 2010-07-01
Primary completion: 2022-06-14
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.